J Pediatr Infect Dis 2020; 15(03): 113-117
DOI: 10.1055/s-0040-1702216
Review Article
Georg Thieme Verlag KG Stuttgart · New York

New Biomarkers Used in the Diagnosis of Tuberculosis-Related Pleural Effusions

1   Department of Chest Diseases, Meram Medical School, Necmettin Erbakan University, Konya, Turkey
› Author Affiliations
Further Information

Publication History

20 September 2019

15 January 2020

Publication Date:
19 February 2020 (online)

Abstract

Tuberculosis-related pleural effusion (TPE) is reported in 12 to 38% of thoracic tuberculosis (TB) cases in the pediatric population. In TPE, the pleural fluid bacilli load is very low, generally resulting in negative acid-fast bacill (AFB) staining and Mycobacterium culture. In the pleural fluid, AFB stain positivity is reported in <20%, and Mycobacterium tuberculosis positive culture in 18 to 38%. In childhood, this ratio is even lower. Also, pleural effusion (PE) mycobacterial culture gives late results (2–8 weeks). Therefore, TPE is diagnosed with pleura biopsy and pleural liquid examination. However, pleura biopsy is a more invasive operation and the diagnosis rates vary. The clinical and laboratory findings are not typical; it is very hard to distinguish between TPE and another cause of exudative PE. This situation makes it essential for research on reliable new biomarkers that can provide fast and accurate diagnosis of TPE. Adenosine deaminase (ADA) activity being above 40 to 50 U/L (despite varying depending on age) strongly suggests TPE. Other new biomarkers featured in TPE diagnosis are interferon-γ, cytokines, and nucleic acid multiplication tests. However, the results of ADA and other potential biomarkers shown to be beneficial in TPE diagnosis should always be interpreted with clinical and microbiological findings because no biomarker can provide information about M. tuberculosis culture and drug resistance. Especially in countries with high resistance against TB drugs, performing pleura biopsy, culture and drug resistance tests are important with regard to diagnosis and therapy planning.

 
  • References

  • 1 Jeon D. Tuberculous pleurisy: an update. Tuberc Respir Dis (Seoul) 2014; 76 (04) 153-159
  • 2 Cruz AT, Ong LT, Starke JR. Childhood pleural tuberculosis: a review of 45 cases. Pediatr Infect Dis J 2009; 28 (11) 981-984
  • 3 Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131 (03) 880-889
  • 4 Porcel JM. Biomarkers in the diagnosis of pleural diseases: a 2018 update. Ther Adv Respir Dis 2018; 12: 1753466618808660
  • 5 Wang JL, Zhao GW, Zhang ZQ, Wang XF, Wang MS. Clinicopathologic characteristics of pediatric tuberculous pleural effusion: a retrospective analysis of 112 consecutive cases. Eur Rev Med Pharmacol Sci 2015; 19 (16) 2978-2982
  • 6 Fischer GB, Andrade CF, Lima JB. Pleural tuberculosis in children. Paediatr Respir Rev 2011; 12 (01) 27-30
  • 7 Wu YB, Ye ZJ, Qin SM, Wu C, Chen YQ, Shi HZ. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy. Chin Med J (Engl) 2013; 126 (17) 3215-3221
  • 8 Ogata Y, Aoe K, Hiraki A. , et al. Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?. Acta Med Okayama 2011; 65 (04) 259-263
  • 9 Porcel JM. Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med 2013; 34 (01) 27-37
  • 10 McGrath EE, Warriner D, Anderson PB. The use of non-routine pleural fluid analysis in the diagnosis of pleural effusion. Respir Med 2010; 104 (08) 1092-1100
  • 11 Gui X, Xiao H. Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis. Int J Clin Exp Med 2014; 7 (10) 3126-3135
  • 12 Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. BMJ 1978; 2 (6154): 1751-1752
  • 13 Gorguner M, Cerci M, Gorguner I. Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions. Respirology 2000; 5 (04) 321-324
  • 14 Poyraz B, Kaya A, Ciledağ A, Oktem A, Gönüllü U. Diagnostic significance of gamma-interferon in tuberculous pleurisy. Tuberk Toraks 2004; 52 (03) 211-217
  • 15 Tozkoparan E, Deniz O, Cakir E. , et al. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy. Int J Tuberc Lung Dis 2005; 9 (09) 1040-1045
  • 16 Celik G, Kaya A, Poyraz B. , et al. Diagnostic value of leptin in tuberculous pleural effusions. Int J Clin Pract 2006; 60 (11) 1437-1442
  • 17 Yildiz PB, Yazar EE, Gorgun D, Secik F, Cakir G. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey. Asian Pac J Cancer Prev 2011; 12 (02) 419-423
  • 18 Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003; 7 (08) 777-786
  • 19 Goto M, Noguchi Y, Koyama H, Hira K, Shimbo T, Fukui T. Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis. Ann Clin Biochem 2003; 40 (Pt 4): 374-381
  • 20 Morisson P, Neves DD. Evaluation of adenosine deaminase in the diagnosis of pleural tuberculosis: a Brazilian meta-analysis. J Bras Pneumol 2008; 34 (04) 217-224
  • 21 Palma RM, Bielsa S, Esquerda A, Martínez-Alonso M, Porcel JM. Diagnostic accuracy of pleural fluid adenosine deaminase for diagnosing tuberculosis. Meta-analysis of Spanish studies. Arch Bronconeumol 2019; 55 (01) 23-30
  • 22 Tay TR, Tee A. Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion: a retrospective cohort study. BMC Infect Dis 2013; 13: 546
  • 23 Abrao FC, de Abreu IR, Miyake DH, Busico MA, Younes RN. Role of adenosine deaminase and the influence of age on the diagnosis of pleural tuberculosis. Int J Tuberc Lung Dis 2014; 18 (11) 1363-1369
  • 24 Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010; 21 (05) 419-423
  • 25 Zemlin AE, Burgess LJ, Carstens ME. The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions. Int J Tuberc Lung Dis 2009; 13 (02) 214-220
  • 26 Valdés L, San José E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J 1996; 9 (04) 747-751
  • 27 Pérez-Rodríguez E, Pérez Walton IJ, Sanchez Hernández JJ. , et al. ADA1/ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid. Respir Med 1999; 93 (11) 816-821
  • 28 Wu YB, Ye ZJ, Qin SM, Wu C, Chen YQ, Shi HZ. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy. Chin Med J (Engl) 2013; 126 (17) 3215-3221
  • 29 Wang H, Yue J, Yang J, Gao R, Liu J. Clinical diagnostic utility of adenosine deaminase, interferon-γ, interferon-γ-induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions. Heart Lung 2012; 41 (01) 70-75
  • 30 Bielsa S, Palma R, Pardina M, Esquerda A, Light RW, Porcel JM. Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. Int J Tuberc Lung Dis 2013; 17 (01) 85-89
  • 31 Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM. Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS One 2008; 3 (07) e2788
  • 32 Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007; 131 (04) 1133-1141
  • 33 Krenke R, Korczyński P. Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med 2010; 16 (04) 367-375
  • 34 Söderblom T, Nyberg P, Teppo AM, Klockars M, Riska H, Pettersson T. Pleural fluid interferon-γ and tumour necrosis factor-α in tuberculous and rheumatoid pleurisy. Eur Respir J 1996; 9 (08) 1652-1655
  • 35 Zhou Q, Chen YQ, Qin SM, Tao XN, Xin JB, Shi HZ. Diagnostic accuracy of T-cell interferon-γ release assays in tuberculous pleurisy: a meta-analysis. Respirology 2011; 16 (03) 473-480
  • 36 Ates G, Yildiz T, Ortakoylu MG. , et al. Adapted T cell interferon-gamma release assay for the diagnosis of pleural tuberculosis. Respiration 2011; 82 (04) 351-357
  • 37 Kang JY, Rhee CK, Kang NH, Kim JS, Yoon HK, Song JS. Clinical utility of two interferon-gamma release assays on pleural fluid for the diagnosis of tuberculous pleurisy. Tuberc Respir Dis (Seoul) 2012; 73 (03) 143-150
  • 38 Wang W, Zhou Q, Zhai K. , et al. Diagnostic accuracy of interleukin 27 for tuberculous pleural effusion: two prospective studies and one meta-analysis. Thorax 2018; 73 (03) 240-247
  • 39 Sehgal IS, Dhooria S, Aggarwal AN, Behera D, Agarwal R. Diagnostic performance of Xpert MTB/RIF in tuberculous pleural effusion: systematic review and meta-analysis. J Clin Microbiol 2016; 54 (04) 1133-1136
  • 40 Pai M, Flores LL, Hubbard A, Riley LW, Colford Jr JM. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis 2004; 4: 6
  • 41 Shen Y, Yang T, Jia L. , et al. A potential role for D-dimer in the diagnosis of tuberculous pleural effusion. Eur Rev Med Pharmacol Sci 2013; 17 (02) 201-205
  • 42 Trajman A, Pai M, Dheda K. , et al. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?. Eur Respir J 2008; 31 (05) 1098-1106
  • 43 Kunter E, Cerrahoglu K, Ilvan A. , et al. The value of pleural fluid anti-A60 IgM in BCG-vaccinated tuberculous pleurisy patients. Clin Microbiol Infect 2003; 9 (03) 212-220
  • 44 Kohmo S, Kijima T, Mori M. , et al. CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy. Tuberculosis (Edinb) 2012; 92 (03) 248-252
  • 45 Kim HR, Jun CD, Lee KS. , et al. Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease. Cytokine 2012; 58 (03) 336-343
  • 46 Yang WB, Liang QL, Ye ZJ. , et al. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions. PLoS One 2012; 7 (07) e40450
  • 47 Hsieh WY, Kuan TC, Cheng KS. , et al. ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions. Int J Biol Sci 2012; 8 (08) 1197-1205
  • 48 Ibrahim L, Salah M, Abd El Rahman A, Zeidan A, Ragb M. Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions. Immunol Invest 2013; 42 (02) 122-136
  • 49 Wang XF, Wu YH, Jiao J, Guan CP, Yang XG, Wang MS. Diagnostic value of superoxide dismutase in tuberculous and malignant pleural effusions. Asian Pac J Cancer Prev 2013; 14 (02) 821-824
  • 50 Elgün S, Kaçmaz B, Durak I. A potential role for nitric oxide pathway in tuberculous pleural effusion. Int J Tuberc Lung Dis 2005; 9 (03) 339-343
  • 51 Suzuki Y, Miwa S, Akamatsu T. , et al. Indoleamine 2,3-dioxygenase in the pathogenesis of tuberculous pleurisy. Int J Tuberc Lung Dis 2013; 17 (11) 1501-1506
  • 52 Xuan WX, Zhang JC, Zhou Q, Yang WB, Ma LJ. IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions. Oncol Lett 2014; 8 (01) 449-453
  • 53 Tural Önür S, Sökücü SN, Dalar L, Seyhan EC, Akbaş A, Altin S. Are soluble IL-2 receptor and IL-12p40 levels useful markers for diagnosis of tuberculous pleurisy?. Infect Dis (Lond) 2015; 47 (03) 150-155